Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices 10235 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Therapeutics Delivery for Neurodegenerative 

Diseases. 

Date: March 12, 2007 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Manfred Schubert, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2212, 

MSC 7890, Bethesda, MD 20892, (301) 435–

6781. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitation imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 DIG 

F(02) M, XNDA Member Conflict. 

Date: March 13, 2007. 

Time: 11 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ross M. Shayiq, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435–

2359, shayiqr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, KNOD 

Members Applications. 

Date: March 15–16, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: William N. Elwood, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3162, 

MSC 7770, Bethesda, MD 20892, (301) 435–

1503, elwoodwi@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, The Global 

Behavioral and Social Science Meeting. 

Date: March 19–21, 2007. 

Time: 8 a.m. to 10 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Dan D. Gerendasy, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5132, 

MSC 7843, Bethesda, MD 20892, (301) 594–

6830, gerendad@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Hypersensitivity, Autoimmune, and Immunemediated Diseases: Member Conflicts. 

Date: March 27–28, 2007. 

Time: 8 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Stephen M. Nigida, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4212, 

MSC 7812, Bethesda, MD 20892, (301) 435–

1222, nigidas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Mechanisms 

of Neurodegeneration. 

Date: March 29, 2007. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Toby Behar, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7850, Bethesda, MD 20892, (301) 435–

4433, behart@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Developmental Biology and Mineralization of 

the Dental and Craniofacial Sciences-A, 

Special Emphasis Panel. 

Date: April 2, 2007. 

Time: 10 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Tamizchelvi Thyagarajan, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4016K, 

MSC 7814, Bethesda, MD 20892, (301) 451–

1327, tthyagar@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 27, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1023 Filed 3–6–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal property. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Opportunistic Pathogens in AIDS. 

Date: March 28, 2007. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Mary Clare Walker, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5208, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1165, walkermc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Muscle 

Physiology. 

Date: March 28, 2007. 

Time: 1:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jo Pelham, BA, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4102, MSC 7814, 

Bethesda, MD 20892, (301) 435–1786, 

pelhamj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Angiogenesis. 

Date: March 28, 2007. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Bukhtiar H. Shah, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4095J, 

MSC 7822, Bethesda, MD 20892, (301) 435–

1233, shahb@csr.nih.gov. 


sroberts on PROD1PC70 with NOTICES
10236 Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.844, 93.846–93.878, 

93.892, National Institutes of Health, HHS) 

Dated: February 28, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1030 Filed 3–6–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Institutes of Health Peer 

Review Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Institutes of 

Health Peer Review Advisory Committee. 

Date: April 19, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: Provide technical and scientific 

advice to the Director, National Institutes of 

Health (NIH), the Deputy Director for 

Extramural Research, NIH and the Director, 

Center for Scientific Review (CSR), on 

matters relating broadly to review procedures 

and policies for the evaluation of scientific 

and technical merit of applications for grants 

and awards. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Rooms 

E1–E2, Bethesda, MD 20892. 

Contact Person: Cheryl A. Kitt, PhD, 

Executive Secretary, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3030, MSC 7776, 

Bethesda, MD 20892, 301–435–1112, 

kittc@csr.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted strigent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 28, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1032 Filed 3–6–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Semescence 

and Stem Cells. 

Date: March 10, 2007. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: James Harwood, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7840, Bethesda, MD 20892, 301–435–

1256, harwoodj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 28, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1034 Filed 3–6–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Bureau of Customs and Border 

Protection 

Notice of Cancellation of Customs 

Broker Permit 

AGENCY: Bureau of Customs and Border 

Protection, U.S. Department of 

Homeland Security. 

ACTION: General Notice. 

SUMMARY: Pursuant to section 641 of the 

Tariff Act of 1930, as amended, (19 

U.S.C. 1641) and the Customs 

Regulations (19 CFR 11 1.51), the 

following Customs broker permits are 

cancelled without prejudice. 

Name Permit No. Issuing Port 

HYC Logistics, Inc. .......................................................................................................................................... 28–05–E69 San Francisco. 

Braverman Enterprises, Inc. ........................................................................................................................... 200113 Los Angeles. 

Martin, Kassatly & Company .......................................................................................................................... 13056–P San Francisco. 

Cornerstone Logistics, Inc. ............................................................................................................................. 17392–P San Francisco. 

Alfredo Mesa ................................................................................................................................................... 52–04–B IC Miami. 

BLG, Inc. ......................................................................................................................................................... 081 New York. 

Gallagher Transport International, Inc. ........................................................................................................... 0158 St. Louis. 

Exel Global Logistics, Inc. ............................................................................................................................... 3501–01–0063 Minneapolis. 

Exel Global Logistics, Inc. ............................................................................................................................... 5398–001 Houston. 

Exel Global Logistics, Inc. ............................................................................................................................... 26–01–006 Nogales. 

Exel Global Logistics, Inc. ............................................................................................................................... 4979–P San Francisco. 

David II Kim Dba ACE American Express ...................................................................................................... 94014 Los Angeles. 

Charter Brokerage Corp. ................................................................................................................................. 53–03–U14 Houston. 


sroberts on PROD1PC70 with NOTICES